Atezolizumab: as a tool

8 studies: an imaging tracer or a test of drug response. Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal CancerRecruitingNCT04564482Not applicableReport a problem
• Implantable Microdevice for TNBC - Pilot StudyWithdrawnNCT05774886Phase 1Report a problem
• PD-L1 PET-imaging During CAR T-cell TherapyActive, not recruitingNCT05404048Phase 2Report a problem
• 89Zr-atezolizumab PET Scan and Lobular Breast CancerTerminatedNCT04222426Not applicableReport a problem
• 89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell CarcinomaActive, not recruitingNCT04006522Phase 2Report a problem
• Molecular Imaging Using Radiolabeled Atezolizumab to Assess Atezolizumab Biodistribution in Lymphoma PatientsWithdrawnNCT03850028Not applicableReport a problem
• Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue SarcomaCompletedNCT03056599Phase 1Report a problem
• MPDL3280A-imaging-IST-UMCGActive, not recruitingNCT02453984Not applicableReport a problem

← Atezolizumab